Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-05

Clinical Trial Update: Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports safety data and antidepressant effects of the investigational drug Rellidep in adults with major depressive disorder based on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rellidep (Rellidep)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED